NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹1,359 Cr | ₹1,013 Cr | ₹765 Cr | ₹472 Cr | ₹312 Cr |
What is the latest Appropriations of NEULAND LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹1,359 Cr |
| Mar2025 | ₹1,013 Cr |
| Mar2024 | ₹765 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹312 Cr |
How is Appropriations of NEULAND LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,359 Cr | 34.17 | |
| Mar2025 | ₹1,013 Cr | 32.31 | |
| Mar2024 | ₹765 Cr | 62.26 | |
| Mar2023 | ₹472 Cr | 51.18 | |
| Mar2022 | ₹312 Cr | - | |
Compare Appropriations of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹28,829.2 Cr | 2.9% | 1.4% | 64.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2.9% |
1.4% |
64.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses